Collins Helen Louise — SEC insider filings

SEC reporting owner CIK 1701247. 34 insider filings on record with FilingPulse; latest filed 2026-11-19.

Transaction summary — filings shown

Covers all 34 filings on record, filed 2020-08-24 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Enliven Therapeutics, Inc. (ELVN)CHIEF MEDICAL OFFICER19—29 legs · 190,816 sh · $6,340,22836
FIVE PRIME THERAPEUTICS, INC. (FPRX)EVP and Chief Medical Officer6——19
Kura Oncology, Inc. (KURA)Director6——7
IO Biotech, Inc. (IOBT)Director3——3

Insider filings — Collins Helen Louise

FiledFormIssuerReported transactionsSource
2026-11-194Enliven Therapeutics, Inc. (ELVN)Option exercise (M): 5,000 @ $2.48 · Sale (S): 4,939 @ $46.83 · Sale (S): 61 @ $47.60 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-10-214Enliven Therapeutics, Inc. (ELVN)Option exercise (M): 5,000 @ $2.48 · Sale (S): 5,000 @ $38.47 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-09-214Enliven Therapeutics, Inc. (ELVN)Option exercise (M): 5,000 @ $2.48 · Sale (S): 2,916 @ $50.03 · Sale (S): 1,844 @ $50.71 · Sale (S): 240 @ $51.48 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-08-194Enliven Therapeutics, Inc. (ELVN)Option exercise (M): 5,000 @ $2.48 · Sale (S): 3,900 @ $58.37 · Sale (S): 1,100 @ $59.35 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-07-214Enliven Therapeutics, Inc. (ELVN)Option exercise (M): 5,000 @ $2.48 · Sale (S): 231 @ $50.05 · Sale (S): 459 @ $51.55 · Sale (S): 2,063 @ $52.39 · Sale (S): 2,184 @ $53.42 · Sale (S): 63 @ $53.92 · +1 moreEDGAR
2026-06-224Enliven Therapeutics, Inc. (ELVN)Option exercise (M): 5,000 @ $2.48 · Sale (S): 1,268 @ $42.83 · Sale (S): 2,599 @ $43.87 · Sale (S): 1,133 @ $44.74 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-06-044Kura Oncology, Inc. (KURA)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2026-05-204Enliven Therapeutics, Inc. (ELVN)Option exercise (M): 5,000 @ $2.48 · Sale (S): 3,475 @ $39.53 · Sale (S): 1,302 @ $40.25 · Sale (S): 223 @ $41.21 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-04-214Enliven Therapeutics, Inc. (ELVN)Option exercise (M): 5,000 @ $2.48 · Sale (S): 140 @ $45.81 · Sale (S): 2,419 @ $47.39 · Sale (S): 2,441 @ $48.06 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-03-274Enliven Therapeutics, Inc. (ELVN)Option exercise (M): 40,000 @ $2.48 · Sale (S): 40,000 @ $35.10 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2026-03-194Enliven Therapeutics, Inc. (ELVN)Option exercise (M): 5,000 @ $2.48 · Sale (S): 5,000 @ $27.76 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-03-114Enliven Therapeutics, Inc. (ELVN)Option exercise (M): 29,871 @ $2.48 · Sale (S): 29,871 @ $30.02 · Option exercise (M): 10,129 @ $2.48 · Sale (S): 10,129 @ $30.19 · Option exercise (M): 29,871 (derivative) @ $0 · Option exercise (M): 10,129 (derivative) @ $0EDGAR
2026-02-194Enliven Therapeutics, Inc. (ELVN)Option exercise (M): 45,000 @ $2.48 · Sale (S): 45,000 @ $26.17 · Option exercise (M): 45,000 (derivative) @ $0EDGAR
2026-02-174Enliven Therapeutics, Inc. (ELVN)Grant/award (A): 25,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $0EDGAR
2025-06-064Kura Oncology, Inc. (KURA)Grant/award (A): 28,500 (derivative) @ $0EDGAR
2025-06-064IO Biotech, Inc. (IOBT)Grant/award (A): 35,144 (derivative) @ $0EDGAR
2025-02-104Enliven Therapeutics, Inc. (ELVN)Grant/award (A): 171,000 (derivative) @ $0EDGAR
2024-10-224Enliven Therapeutics, Inc. (ELVN)Option exercise (M): 816 @ $2.48 · Sale (S): 816 @ $30.00 · Option exercise (M): 816 (derivative) @ $0EDGAR
2024-06-074Kura Oncology, Inc. (KURA)Grant/award (A): 26,000 (derivative) @ $0EDGAR
2024-06-074IO Biotech, Inc. (IOBT)Grant/award (A): 45,642 (derivative) @ $0EDGAR
2024-04-154Enliven Therapeutics, Inc. (ELVN)Option exercise (M): 20,000 @ $2.48 · Sale (S): 20,000 @ $25.07 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2024-02-154Enliven Therapeutics, Inc. (ELVN)Grant/award (A): 185,000 (derivative) @ $0EDGAR
2023-11-174IO Biotech, Inc. (IOBT)Grant/award (A): 64,238 (derivative) @ $0EDGAR
2023-06-024Kura Oncology, Inc. (KURA)Grant/award (A): 26,000 (derivative) @ $0EDGAR
2023-04-064Enliven Therapeutics, Inc. (ELVN)Grant/award (A): 206,000 (derivative) @ $0EDGAR
2023-02-274Enliven Therapeutics, Inc. (ELVN)Grant/award (A): 287,084 (derivative)EDGAR
2022-06-234Kura Oncology, Inc. (KURA)Grant/award (A): 23,000 (derivative) @ $0EDGAR
2021-07-294Kura Oncology, Inc. (KURA)Grant/award (A): 46,000 (derivative) @ $0 · Grant/award (A): 19,166 (derivative) @ $0EDGAR
2021-04-194FIVE PRIME THERAPEUTICS, INC. (FPRX)Gift (G): 8,085 @ $0 · Grant/award (A): 66,000 @ $0 · Disposition to issuer (D): 135,547 @ $38 · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 58,000 (derivative) · +3 moreEDGAR
2021-03-024FIVE PRIME THERAPEUTICS, INC. (FPRX)Tax withholding (F): 1,158 @ $22.23EDGAR
2021-02-264FIVE PRIME THERAPEUTICS, INC. (FPRX)Tax withholding (F): 5,091 @ $25.71 · Tax withholding (F): 1,653 @ $23.08EDGAR
2020-12-154FIVE PRIME THERAPEUTICS, INC. (FPRX)Option exercise (M): 22,000 @ $0 · Tax withholding (F): 11,583 @ $16.14 · Option exercise (M): 22,000 (derivative) @ $0EDGAR
2020-11-134FIVE PRIME THERAPEUTICS, INC. (FPRX)Option exercise (M): 22,000 @ $0 · Tax withholding (F): 11,039 @ $18 · Option exercise (M): 22,000 (derivative) @ $0EDGAR
2020-08-244FIVE PRIME THERAPEUTICS, INC. (FPRX)Tax withholding (F): 827 @ $4.69EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1701247 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs